EClinical Solutions Market size to grow by USD 9.7 billion from 2022 to 2027, North America to account for 41% of market growth, Technavio

NEW YORK, March 6, 2024 /PRNewswire/ — The eclinical solutions market is expected to grow by USD 9.7 billion from 2022 to 2027. In addition, the momentum of the market will progress at a CAGR of  13.47% during the forecast period, according to Technavio Research. The market has been segmented by end-user (pharmaceutical and biotechnology companies, contract research organizations, consulting service companies, medical device manufacturers, and others), deployment (cloud-based and on-premises), and geography (North America, Europe, Asia, and Rest of World (ROW)). North America accounts for 41% of the growth of the global market during the forecast period. Factors such as the easy regulatory process, a large number of pharmaceutical and biotech companies as well as CROs in the region, and large investments in clinical trial research are driving the market growth in North America.

This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment.

Read a Free PDF Sample Report

Key Company

Advarra Inc., Aixial, Anju Software Inc., ArisGlobal LLC, Castor Research Inc., Dassault Systemes SE, DATATRAK International Inc., eClinical Solutions LLC., eClinicalWorks LLC, eResearchTechnology GmbH, International Business Machines Corp., MedNet, Medrio Inc., OpenClinica LLC, Oracle Corp., Parexel International Corp., Saama Technologies Inc., Signant Health, Veeva Systems Inc., and YPrime LLC

Veeva Systems Inc: The company offers eClinical solution such as Veeva Vault CTMS which provides end-to-end study management and monitoring capabilities for insourced and outsourced trials.

 To gain access to more company profiles available with Technavio

Buy the report!

Segmentation Analysis

The market has been segmented by end-user (pharmaceutical and biotechnology companies, contract research organizations, consulting service companies, medical device manufacturers, and others), deployment (cloud-based and on-premises), and geography (North America, Europe, Asia, and Rest of World (ROW)).

The market growth by the pharmaceutical and biotechnology companies segment is significant during the forecast period. In addition, the increasing need for data management has led these companies to adopt eClinical solutions, such as CTMS. 

Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. 

View a Free PDF Sample Report

The rise in clinical trials for drugs drives the market growth.

Some of the factors that are fuelling clinical trials in developing countries include the availability of a skilled workforce and improved clinical trial infrastructure which will increase the use of eClinical solutions at different stages of drug development which will drive the market growth.

  • High adoption of cloud computing is an emerging trend in the market. 

 Identify key trends, drivers, and challenges in the market. 

Download a sample to gain access to this information.

Analyst Review

In the modern healthcare, the eClinical solutions market stands as a pivotal force, reshaping the landscape of clinical trials. These innovative platforms integrate advanced technologies to streamline processes, enhance efficiency, and bolster data management within clinical research endeavors.

The adoption of eClinical solutions has soared in recent years, driven by the pressing need for streamlined and cost-effective approaches to clinical trials. With the proliferation of cloud computing and big data analytics, eClinical solutions offer a comprehensive suite of tools to manage every aspect of a trial, from patient recruitment to data analysis.

One of the key drivers propelling the growth of the eClinical solutions market is the increasing complexity of clinical trials. As studies become more intricate, encompassing diverse therapeutic areas and involving larger patient populations, traditional paper-based methods struggle to keep pace. Here, eClinical solutions provide a lifeline, offering real-time data capture and analysis, thereby expediting trial timelines and reducing overall costs.

Furthermore, regulatory requirements continue to evolve, mandating stringent standards for data integrity and security. eClinical solutions address these concerns by implementing robust compliance features and data encryption protocols, ensuring that sensitive information remains secure throughout the trial process.

In addition to their regulatory compliance capabilities, eClinical solutions empower researchers with advanced reporting functionalities. By aggregating and analyzing clinical data in real-time, these platforms enable stakeholders to make data-driven decisions swiftly, thus accelerating the pace of drug development.

Moreover, the scalability of eClinical solutions renders them suitable for trials of varying sizes and complexities. Whether conducting a small-scale Phase I trial or a large-scale Phase III study, researchers can customize these platforms to meet their specific needs, thereby maximizing efficiency and cost-effectiveness.

Looking ahead, the future of the eClinical solutions market appears exceedingly promising. As the demand for integrated, end-to-end solutions continues to rise, vendors are poised to innovate further, incorporating emerging technologies such as artificial intelligence and machine learning into their offerings.

In conclusion, the eClinical solutions market represents a transformative force within the realm of clinical research. By providing streamlined, compliant, and data-driven solutions, these platforms are revolutionizing the way clinical trials are conducted, ultimately driving advancements in healthcare on a global scale.

Download a sample to gain access to this information.

Related Reports:

The global precision food thermometers market size is estimated to grow by USD 132.71 million at a CAGR of 8.69% between 2023 and 2028. 

The global rehabilitation equipment market size is estimated to grow by USD 3.67 billion at a CAGR of 4.44% between 2023 and 2028. 


1 Executive Summary

2 Landscape

3 Sizing

4 Historic Size

5 Five Forces Analysis

6 Segmentations

7 Customer Landscape

8 Geographic Landscape

9 Drivers, Challenges, and Trends

10 Vendor Landscape

11 Vendor Analysis

12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.


Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200



Cision View original content to download multimedia:–north-america-to-account-for-41-of-market-growth-technavio-302080933.html

SOURCE Technavio

Leave a Comment